NewsInnovative Trials2024-11-25T12:21:32+00:00

IT logotype with strapline_on dark backgrounds 1300x264px

News

Stay updated with the latest news from Innovative Trials

Call for more BAME representation in COVID-19 trials

Phil Long2022-09-16T16:31:40+01:00October 13th, 2020|

Call for more BAME representation in COVID-19 trials will fail if long-held diversity challenges are not addressed, says

Clinical trials company warns against public panic in light of Oxford COVID-19 trial being halted

Phil Long2022-02-04T17:11:56+00:00September 11th, 2020|

Clinical trials company warns against public panic in light of Oxford COVID-19 trial being halted Wednesday 9 September

Clinical trials company calls for unity and action to address lack of patient diversity

Phil Long2022-02-04T17:10:47+00:00May 21st, 2020|

Clinical trials company calls for unity and action to address lack of patient diversity in research Wednesday 20th

Clinical trials company recognised with royal business award

Phil Long2022-02-04T17:10:59+00:00April 21st, 2020|

Clinical trials company recognised with royal business award Tuesday, 21st April 2020 Clinical trial patient recruitment company, Innovative

New initiative to give cancer patients easier access to clinical trials and increase patient diversity in research

Innovative Trials2022-02-04T17:11:41+00:00March 13th, 2020|

New initiative to give cancer patients easier access to clinical trials and increase patient diversity in research

Hertfordshire company bucks economic trend to become multi-million pound business

Phil Long2023-04-17T16:00:59+01:00June 24th, 2019|

Hertfordshire company bucks economic trend to become multi-million pound business Date: Monday 24 June

Learn more how we accelerate patient recruitment

Therapy Areas

We have extensive experience of study phases I to IV, adults and paediatrics and both acute and chronic conditions.

Analgesics

Intra Abdominal pain
Post Operative pain

General Medicine

Non Alcoholic Fatty Liver Disease (NAFLD)
Non Alcoholic Steatohepatitis (NASH)
Hypercholesterolaemia
Type II Diabetes

Haematology

Anaemia
Haemophilia
Sickle Cell
Thrombocytopenia

Bone

Osteoarthritis

Dermatology

Atopic Dermatitis
Hidradenitis Suppurativa
Psoriasis

Gastroenterology

Crohn’s Disease
Ulcerative Colitis

Infection

Bacterial infection – Sepsis
C-Diff
Intra-abdominal Infectious Disease
Pneumonia

Immunology

Ankylosing Spondylitis
Alopecia
Asthma
Atopic Dermatitis
Crohn’s Disease
Hidradenitis Suppurativa
Lupus
Nasal Polyps
Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
Ulcerative Colitis
Vitiligo

Neuroscience/CNS

Alzheimer’s Disease
Epilepsy
Depression
Duchenne Muscular Dystrophy (DMD)
Dyskinesia in Cerebral Palsy
Migraine
Multiple Sclerosis
Parkinson’s Disease
Schizophrenia

Oncology

Acute Myeloid Leukaemia
Basal Cell Carcinoma
Bladder Cancer
Breast Cancer
Colorectal Cancer
Gastric Cancer
Head & Neck Cancer
Liver Cancer
Lung Cancer
Lymphoma
Metastatic Bone Pain
Myelofibrosis
Mutant Tumours
NSCLC
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Solid Tumour
Treatment Resistance Post Cancer Treatment
Urothelial Cancer

Respiratory

Asthma
COPD

Urology

Over-active Bladder

Vaccines

Pneumonia
Urinary Tract Infection

Vascular Disease

Stroke

Women’s Health

Birth Control
Interstitial Cystitis
STD Prevention
Urinary Tract Infection

Do you need to minimise the impact on your clinical trials, or boost patient recruitment in your Covid-19 studies?

Let’s talk

You are one step away from discovering how we can work side by side to support your patient recruitment needs.